The Best Mobile Gaming Controllers in 2024
Lineage Logistics Doing $130 Million Expansion In Hobart With Massive Concrete Pour Requiring 150 Trucks
Lineage Logistics in Hobart is doing a $130 million expansion that will involve a massive continuous concrete pour this weekend in Hobart.
The suburban Detroit-based company plans to add 180,000 square feet of cold storage space at its campus at 2201 Northwind Parkway in the Northwind Crossings business park, and to hire 90 more permanent full-time workers. The company hopes to open a new fully automated rack support building by 2025.
About 150 concrete trucks will make at least nine trips to the work site starting at 1 a.M. Saturday for what Mayor Josh Huddlestun describes as "one of the longest continuous concrete pours in world history, right here in Hobart, Indiana."
"It's pretty big," he said. "It shows their commitment to the area and the work we've done here. They're expanding, reinvesting in the area and growing their workforce."
People are also reading…
Huddlestun is encouraging drivers to avoid the Northwinds Crossing business park during the project this weekend. It's located southeast of the 61st Street exit off of Interstate 65, between Mississippi Street and Colorado Street.
"Almost every road in the city is under construction right now," he said. "Drivers should stay away from the concrete pour. There's going to be a lot of concrete trucks."
Five to seven concrete plants will serve the massive project. Ozinga, the concrete giant known for its red-and-white-striped trucks, is throwing a ton of resources at the project.
"It's one of Ozinga's largest pours," Huddlestun said. "It goes to show Northwest Indiana and Hobart are hotbeds for development. Northwinds has been a tremendous industrial park development for us. It showed it could be done in Northwest Indiana and had a ripple effect across the Region."
Lineage Logistics is a global giant that claims to be the "world's largest temperature-controlled warehouse real estate investment trust." It operates 450 cold storage facilities in 18 countries exceeding three billion cubic feet of space.
It employs 26,000 workers, who often work in subzero warehouses to preserve food and other perishables.
The expansion in Hobart would have given Lineage Logistics the largest cold storage warehouse in Northwest Indiana, but it has since been eclipsed by plans for the CoreX project in Crown Point and the US Cold Storage project in Lowell, said Randy Palmateer, business manager of the Northwestern Indiana Building and Construction Trades Council.
Palmateer has been in talks with the contractor Victory about hiring local union labor for the project, which is expected to create 300 to 500 construction jobs.
"The conversations have been good," he said. "We're not there but we're working on an agreement on how they're going to build it. We're still in negotiations to build it with local union labor. We're still trying to work out the kinks but they're minor. We appreciate Victory, the new mayor Josh Huddlestun, the council and the city of Hobart for supporting the local workforce."
Lineage Logistics initially had been looking to bring in outside labor because of the specialized nature of the project. Local unions tradesmen have experience building cold storage facilities like Dawn Foods in Merrillville.
"We build refineries, steel mills and boats in the moat casinos," Palmateer said. "We can build anything from a birdhouse to a refinery on time and under budget. We spend $60 million training our apprentices every year to make sure they can tackle any project."
Beer Geeks, one of the Region's first, most beloved and most influential craft beer bars, closed after more than a decade and is being reimagined as a new concept.
The landmark 88-year-old castle-shaped White Castle in Whiting is coming down to be replaced with a newer, larger, more modern White Castle restaurant.
A longtime staple in downtown Crown Point poured its last drink.
The longtime Westforth Sports gun shop is closing.
The Silver Line Building Products plant at 16801 Exchange Ave. Will be shuttered permanently.
Localbusinesses
Brewfest in Highland will close in what's been called "an end of an era."
David's Bridal filed for bankruptcy and could close all stores if no buyer emerges to save it.
The 88-year-old Whiting White Castle will be remembered with displays at museums in two different states.
alert top story urgent topical
For years, the "millionaire's club" met every morning in the corner booth of the historic 88-year-old White Castle at Indianapolis Boulevard and 119th Street in downtown Whiting. The landmark restaurant served its final slider Tuesday.
One of Northwest Indiana's most popular and enduring hobby shops is looking for a buyer after the longtime owner died.
J&L This N That Consignment Shop, a popular thrift store, closed in downtown Whiting after a run of several years.
A Calumet Region institution, Calumet Fisheries on the far South Side of Chicago, is temporarily closed after failing a city health inspection.
Just days after reopening after city health inspectors shut it down, Calumet Fisheries suffered a major fire.
Pepe's Mexican Restaurant is no mas in Valparaiso.
Beer Geeks in Highland rebranded as B-Side Bar & Lounge and then closed within a few months.
Troubled retailer Bed Bath and Beyond will permanently close its Valparaiso location as it shutters more stores nationwide as it looks to restructure and shrink its footprint to save the struggling business.
Peoples Bank has shuttered its branch in downtown Hammond.
Viking Artisan Ales will soon pour its last craft beer at its Merrillville taproom.
Old Chicago Pizza & Taproom is closing after 15 years at one of Northwest Indiana's most prominent highway interchanges.
Walmart is closing its big-box store in Homewood.
The Chicago Auto Show, the nation's largest auto show, returns to McCormick Place Saturday, running through Feb. 19.
Subscribe to our Daily Headlines newsletter.
Lineage Announces Appointment Of Charlotte Hubbert, Ph.D., As Vice President Of Corporate Development
CARLSBAD, Calif., April 01, 2024--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development. Dr. Hubbert has an extensive background in cell therapy research and venture investment across a broad range of therapeutic modalities and development stages, and has a proven ability to combine deep scientific expertise and business development acumen to identify innovative opportunities to drive both returns and impact. Dr. Hubbert previously served as Partner and Head of Gates Foundation Venture Capital, an initiative at the Bill and Melinda Gates Foundation Strategic Investment Fund, where she oversaw investing in innovative technologies that supported the foundation's programs in global health and agriculture. Most recently, Dr. Hubbert served in the leadership team at NanoString Technologies. She currently serves on the Board of Directors of the Beckman Research Institute at the City of Hope, and is a Strategic Director at Madrona Venture Group.
"We are excited to add such a talented executive to our management team in the newly created position of VP Corporate Development. Dr. Hubbert's decades of experience in cell therapy, strategic investment, and partnering make her a valuable and welcome addition to the Lineage team," stated Brian M. Culley, CEO. "Given her relevant expertise in regenerative medicine, she will be able to support multiple operational areas, including product development, market strategies, strategic partnering, and broaden awareness of the work we're doing to create a leading cell transplant company."
Prior to joining the Bill and Melinda Gates Foundation Strategic Investment Fund, where she led investments and served on the Board of Directors of Synlogic (Nasdaq: SYBX), Sera Prognostics, Lodo Therapeutics, Agtech Accelerator, Vedanta, and Vir Biotechnology (Nasdaq: VIR), Dr. Hubbert was a vice president at H.I.G. BioVentures, investing broadly in healthcare, and began her career in early-stage biotech investing at Accelerator Corporation, where she was a part of the founding management team.
Dr. Hubbert earned a B.S. In microbiology from the University of Washington and a Ph.D. In cancer biology from Duke University for which she received the prestigious Harold Weintraub Award. She did her post-doctoral work in stem cells and regenerative medicine at the Institute for Stem Cells and Regenerative Medicine at the University of Washington. Dr. Hubbert is a member of the Kauffman Society of Fellows and is a Fierce Woman in Biopharma awardee which recognizes top executives in Biopharma. She previously served on the Board of Directors of Life Science Washington, and the steering committees of the Fred Hutch Cancer Institute's Evergreen Fund, University of Washington Innovation Roundtable and Columbia University Lab-to-Market initiative.
Story continues
About Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel or "off-the-shelf," cell therapies to address unmet medical needs. Lineage's programs are based on its proprietary cell-based technology platform and associated development and manufacturing capabilities. From this platform, Lineage designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions similar or identical to cells found naturally in the human body. These cells are created by applying directed differentiation protocols to established, well-characterized, and self-renewing pluripotent cell lines. These protocols generate cells with characteristics associated with specific and desired developmental lineages. Cells derived from such lineages are transplanted into patients in an effort to replace or support cells that are absent or dysfunctional due to degenerative disease, aging, or traumatic injury, and to restore or augment the patient's functional activity. Lineage's neuroscience focused pipeline currently includes: (i) OpRegen, a retinal pigment epithelial cell therapy in Phase 2a development under a worldwide collaboration with Roche and Genentech, a member of the Roche Group, for the treatment of geographic atrophy secondary to age-related macular degeneration; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of spinal cord injuries; (iii) ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; (iv) PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and (v) RND1, a novel hypoimmune induced pluripotent stem cell line being developed in collaboration with Eterna Therapeutics Inc. For more information, please visit www.Lineagecell.Com or follow the company on X/Twitter @LineageCell.
Forward-Looking Statements
Lineage cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as "believe," "aim," "may," "will," "estimate," "continue," "anticipate," "design," "intend," "expect," "could," "can," "plan," "potential," "predict," "seek," "should," "would," "contemplate," "project," "target," "tend to," or the negative version of these words and similar expressions. Such statements include, but are not limited to, statements relating to: the anticipated or implied benefits of Dr. Hubbert's employment with Lineage. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Lineage's actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including, but not limited to, those risks and uncertainties inherent in Lineage's business and other risks discussed in Lineage's filings with the Securities and Exchange Commission (SEC). Lineage's forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. Further information regarding these and other risks is included under the heading "Risk Factors" in Lineage's periodic reports with the SEC, including Lineage's most recent Annual Report on Form 10-K filed with the SEC and its other reports, which are available from the SEC's website. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.
View source version on businesswire.Com: https://www.Businesswire.Com/news/home/20240401267142/en/
Contacts
Lineage Cell Therapeutics, Inc. IRIoana C. Hone(ir@lineagecell.Com)(442) 287-8963
LifeSci AdvisorsDaniel Ferry(daniel@lifesciadvisors.Com)(617) 430-7576
Russo Partners – Media RelationsNic Johnson or David Schull(Nic.Johnson@russopartnersllc.Com)(David.Schull@russopartnersllc.Com)(212) 845-4242
View comments
Lineage Logistics Announces Rebranding, Changes Brand Name To Lineage
NOVI, Mich.–(BUSINESS WIRE)–#oneLineage—Lineage (the "Company"), one of the leading temperature-controlled industrial REIT and logistics solutions providers worldwide, has announced a rebranding, formally changing its brand name from Lineage Logistics to Lineage.
Established in 2012, the Lineage name reflects the company's unique legacy and expertise in the interconnected world of cold storage and logistics. The company's shield logo signifies the generational and entrepreneurial commitment of the many companies that have been welcomed into the Lineage family through over 110 acquisitions to form Lineage with the shared charge of keeping the global food supply safe and accessible.
Today, Lineage is responsible for storing, handling, and transporting food products across the U.S. And around the globe, operating over 480 warehouses in 18 countries with more than 26,000 dedicated employees. With over 12,000 customers globally, Lineage's end-to-end logistical solutions, unrivaled real estate network, and application of innovative technology help to increase distribution efficiency, advance sustainability, lessen environmental impact, minimize supply chain waste and, most importantly, help feed the world.
"Our brand name change honors our heritage while also reflecting Lineage's vision and dedication toward reimagining the world's food supply for generations to come," said Greg Lehmkuhl, President and CEO of Lineage. "We remain steadfast in our commitment to continuous improvement and advancing Silicon Valley-style innovation across the cold chain to protect and optimize the distribution of food to families globally."
The new brand name will begin appearing immediately in communications, advertising and on Lineage's new website at www.Onelineage.Com (previously LineageLogistics.Com).
About Lineage
Lineage, Inc. Is the world's largest global temperature-controlled warehouse REIT with a network of over 480 strategically located facilities totaling over 84.1 million square feet and 3.0 billion cubic feet of capacity across countries in North America, Europe, and Asia-Pacific. Coupling end-to-end supply chain solutions and technology, Lineage partners with some of the world's largest food and beverage companies to help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, feed the world.
Contacts
Megan Hendricksen
949-247-5172
mhendricksen@onelineage.Com
Comments
Post a Comment